PETRI DISH PERSPECTIVES

← PETRI DISH PERSPECTIVES3 sep · 22 min

Episode 71: Fate of Pharma M&A

Episode 71: Fate of Pharma M&A3 sep22 min

Send us Fan Mail In this episode of Petri Dish Perspectives, we take a step back from individual companies to examine one of the most powerful forces shaping the pharmaceutical industry: M&A, licensing, and the global competition for innovation. We explore how today's pharmaceutical giants were built through decades of consolidation, from Pfizer, GlaxoSmithKline, and Novartis to some of the industry's biggest modern transactions and why dealmaking has increasingly become essential for com...